IMU 4.00% 4.8¢ imugene limited

Check-vacc - possible complete response case study!, page-59

  1. 2,531 Posts.
    lightbulb Created with Sketch. 272
    OK... have just received a reply to my question (from Nick Ede)...

    "to keep the data clean and by clinical trial protocol methodology patients remain in their designated cohort and hence dose level"

    Great communication between company and shareholders!

    MTW
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.